Number of drug ads screening cases in first half down 27 percent

Published: 2003-06-26 07:00:00

Updated: 2003-06-26 07:00:00

Amid protracted pharmaceutical business setbacks and sluggish sales in OTCs, the number of OTC ads screening cases in the first half of this year decreased sharply, said an ads screening committee recently.

The Drug Ads Deliberation Committee under the Korea Pharmaceutical Manufacturers Associ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK